Investment ThemesDetailed Quotes
Mpox (monkeypox)
Watchlist
- 1238.572
- -0.994-0.08%
Close Feb 18 16:00 ET
1241.774High1233.971Low
1239.613Open1239.566Pre Close31.81MVolume7RiseLossP/E (Static)1.91BTurnover--Flatline0.33%Turnover Ratio637.77BMarket Cap7Fall635.77BFloat Cap
Constituent Stocks: 14Top Rising: TTOO+63.93%
The latest stock option grant issued to their staff on 27 February 2025 has an exercise price of $1,777.60. It is ridiculous high. Not sure how they priced their exercise price.
Revolutionary Brain Cancer Drug Gets Fast-Track to FDA Approval: Chimerix's Hope for Untreatable Glioma
Chimerix Announces FDA Acceptance and Priority Review of New Drug Application for Dordaviprone as Treatment for Recurrent H3 K27M-Mutant Diffuse Glioma
Chimerix (NASDAQ: CMRX) announced FDA acceptance of its New Drug Application (NDA) for dordaviprone, targeting recurrent H3 K27M-mutant diffuse glioma treatment. The application received Priority Review status with a PDUFA target action date of August 18, 2025.
The FDA has not planned an advisory committee meeting for th...
Chimerix Announces FDA Acceptance and Priority Review of New Drug Application for Dordaviprone as Treatment for Recurrent H3 K27M-Mutant Diffuse Glioma
65k returned
I've got my eyes on this and will likely be taking a position on Tuesday. Keep it on watch or consider a swing position.
No comment yet